PDF
(Download)
|
- Hibiscus (Hibiscus sabdariffa)
- Obesity
- Liver Steatosis
|
Date:
08-15-2014 | HC# 041424-502
|
Re: Hibiscus Supplementation Resulted in a Decrease in Waist Circumference, Percent Body Fat, Free Fatty Acids, and Waist-to-hip Ratio in Obese Subjects
Chang
HC, Peng CH, Yeh DM, Kao ES, Wang CJ. Hibiscus sabdariffa extract inhibits
obesity and fat accumulation, and improves liver steatosis in humans. Food Funct. April 2014;5(4):734-739.
The
prevalence of obesity has increased throughout the industrialized world over
the past 3 decades. Obesity is correlated with a number of serious illnesses,
including cardiovascular disease, type 2 diabetes, cancer, and metabolic
syndrome. Individuals with metabolic syndrome generally have higher than normal
body fat and abdominal fat, high serum levels of triglycerides and low-density
lipoproteins (LDLs), low serum levels of high-density lipoproteins (HDLs), and
low free fatty acid (FFA) flux. Liver steatosis is the accumulation of fat in
the liver and is often seen in obese individuals. In severe cases of liver
steatosis, the liver can become inflamed and cell death can occur. Hibiscus (Hibiscus sabdariffa) is often used for
the treatment and prevention of hypertension, inflammation, and liver disease. Hibiscus
has been shown to inhibit LDL oxidation and decrease serum levels of
cholesterol in rats and rabbits. These effects are suggested to be due to the
high levels of anthocyanins, flavonoids, and phenolic acid present in hibiscus
extracts. The effect of hibiscus on weight, body fat, serum lipids, and liver
enzymes was measured in this double-blind, randomized, controlled study.
Obese subjects (body
mass index [BMI] ≥ 27 kg/m2) aged 18-65 who had been
diagnosed with fatty liver were recruited to the Chung Shan Medical University
Hospital in Taichung City, Taiwan for a study that took place from July 2007 to
June 2009. Subjects were excluded if they were pregnant; taking medication to
treat fatty liver; consumed more than 19 g of alcohol per day; had high alanine
transaminase (ALT) or bilirubin levels; had a history of kidney,
cardiovascular, or endocrine disease; or were taking over-the-counter,
prescription, or alternative medications.
Subjects were
randomly divided into 2 groups that consumed either 2 hibiscus tablets (450 mg hibiscus
and 50 mg starch) or 2 placebo tablets (500 mg starch), 3 times per day after
meals for 12 weeks. The hibiscus tablets contained aqueous, filtered, dried
extracts of hibiscus flowers. The extract contained 1.43% flavonoids, 2.5%
anthocyanins, and 1.7% phenolic acid. Height, waist-to-hip ratio, BMI, and body
fat were measured at the beginning and end of the study, and weight at 0, 6,
and 12 weeks. Serum lipids, glucose, ALT, aspartate transaminase (AST), and a
number of other serum biomarkers were measured at the beginning and end of the
study. An ultrasound of the liver was conducted, and a fatty liver score (FS)
was calculated at the beginning and end of the study. A lower FS indicates a
healthier liver. Unpaired student t-tests and paired student t-tests were used
to analyze the data.
Of
the 40 subjects that began the study, 4 were removed for non-compliance,
leaving 17 subjects in the placebo group and 19 in the treatment group. At the
beginning of the study, baseline levels of ALT and AST were significantly
higher in the treatment group than in the control group (P = 0.033 and P =
0.049, respectively). No other significant differences were found between the
groups at the beginning of the study.
There
was a significant decrease in waist circumference, percent body fat, and waist-to-hip
ratio in the hibiscus treatment group compared to the control group over the
course of the study (P < 0.038, P < 0.044, and P < 0.026,
respectively). On average, approximately 1.2 kg was lost in the treatment
subjects compared to 0.7 kg in the control group, a statistically insignificant
difference. There was no significant difference in
lipids between the 2 groups. FFA decreased significantly in the hibiscus group
compared to the control group (P = 0.026).
Hibiscus supplementation led to a decrease in waist circumference, percent
body fat, FFA, and waist-to-hip ratio over the 12-week course of this study. Hibiscus contains a number of secondary compounds that have been shown to
affect weight loss and fat metabolism, including galloyl ester, chlorogenic
acid, caffeic acid, quercetin, tiliroside, and anthocyanins. The authors note
that the dosage used may be too low to affect blood lipids and suggest further
research on hibiscus dosage level.
–Cheryl McCutchan,
PhD
|